» Articles » PMID: 30470398

Low-Grade Glioma Radiotherapy Treatment and Trials

Overview
Specialty Neurosurgery
Date 2018 Nov 25
PMID 30470398
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Low-grade gliomas represent an important class of primary brain tumors. They account for approximately 20% of primary brain tumors and typically present in the fourth decade of life. Standard management gliomas involves observation, surgery, chemotherapy, and/or radiotherapy. Treatment decisions are based on many factors including prognostic molecular markers, potential benefits of increased progression-free survival, and potential long-term treatment complications. Recent studies have improved our understanding regarding therapeutic interventions. This review provides an overview of low-grade glioma and discusses the roles of radiation therapy. We discuss advances in techniques and recent and ongoing radiation therapy-related clinical trials for low-grade gliomas.

Citing Articles

EFNB1 drives glioma progression and shapes the immune microenvironment: a potential prognostic biomarker.

Zheng Y, Shi J Discov Oncol. 2025; 16(1):249.

PMID: 40014231 PMC: 11868007. DOI: 10.1007/s12672-025-01867-y.


Computed Tomography-Image-Based Glioma Grading Using Radiomics and Machine Learning: A Proof-of-Principle Study.

Bilgin M, Bilgin S, Akkurt B, Heindel W, Mannil M, Musigmann M Cancers (Basel). 2025; 17(2).

PMID: 39858104 PMC: 11763433. DOI: 10.3390/cancers17020322.


Atorvastatin inhibits glioma glycolysis and immune escape by modulating the miR-125a-5p/TXLNA axis.

Gao K, Zhou T, Yin Y, Sun X, Jiang H, Li T Hereditas. 2024; 161(1):54.

PMID: 39726023 PMC: 11670371. DOI: 10.1186/s41065-024-00349-5.


may predict poor prognosis of lower-grade glioma patients and be a potential target for immunotherapy.

Jia Y, Liu M, Liu H, Liang W, Zhu Q, Wang C Cancer Biol Ther. 2024; 25(1):2425134.

PMID: 39555702 PMC: 11581156. DOI: 10.1080/15384047.2024.2425134.


Screening of potential key pathogenic and intervention targets of low-grade glioma based on bioinformatics.

Yi L, Kong W, Jiu Z, Huang Z, Na P, Chen W Transl Cancer Res. 2024; 13(10):5563-5573.

PMID: 39525013 PMC: 11543039. DOI: 10.21037/tcr-24-1662.